Search research articles
Contact Us
Filters
Showing results (81-90 of 104) with videos related to
Page
of 11
Sort By:
Cell
|
January 29, 1993
Oncogenic activity of the c-Myc protein requires dimerization with Max
B Amati, M W Brooks, N Levy, et al.
Oncogene
|
May 1, 1991
c-myc protein expression in untransformed fibroblasts
C M Waters, T D Littlewood, D C Hancock, et al.
Oncogene
|
March 26, 2014
The kinetics of ER fusion protein activation in vivo
C H Wilson, I Gamper, A Perfetto, et al.
FEBS Letters
|
March 13, 1989
Induction of c-fos protein by activation of vasopressin receptors in smooth muscle cells
P Nambi, R Watt, M Whitman, et al.
The Journal of Clinical Investigation
|
February 1, 1994
Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides
M R Bennett, S Anglin, J R McEwan, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
February 1, 1997
Large induction of c-Myc is not essential for the mitogenic response of Swiss 3T3 fibroblasts
H Mehmet, T D Littlewood, J Sinnett-Smith, et al.
Journal of Clinical Pathology
|
November 1, 1987
Abnormal distribution of c-myc oncogene product in familial adenomatous polyposis
V Sundaresan, I C Forgacs, D G Wight, et al.
Cell Death & Disease
|
January 26, 2013
Sequential Cdk1 and Plk1 phosphorylation of protein tyrosine phosphatase 1B promotes mitotic cell death
D S O'Donovan, S MacFhearraigh, J Whitfield, et al.
The EMBO Journal
|
October 1, 1986
Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells
D T Rowe, M Rowe, G I Evan, et al.
Experimental Nephrology
|
March 1, 1994
Transduction pathways for growth stimulatory and inhibitory actions of vasoactive agents
A C Newby, J W Assender, M A Evans, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 104) with videos related to
Sort By:
Page
of 11
Cell
|
January 29, 1993
Oncogenic activity of the c-Myc protein requires dimerization with Max
B Amati, M W Brooks, N Levy, et al.
Oncogene
|
May 1, 1991
c-myc protein expression in untransformed fibroblasts
C M Waters, T D Littlewood, D C Hancock, et al.
Oncogene
|
March 26, 2014
The kinetics of ER fusion protein activation in vivo
C H Wilson, I Gamper, A Perfetto, et al.
FEBS Letters
|
March 13, 1989
Induction of c-fos protein by activation of vasopressin receptors in smooth muscle cells
P Nambi, R Watt, M Whitman, et al.
The Journal of Clinical Investigation
|
February 1, 1994
Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides
M R Bennett, S Anglin, J R McEwan, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|
February 1, 1997
Large induction of c-Myc is not essential for the mitogenic response of Swiss 3T3 fibroblasts
H Mehmet, T D Littlewood, J Sinnett-Smith, et al.
Journal of Clinical Pathology
|
November 1, 1987
Abnormal distribution of c-myc oncogene product in familial adenomatous polyposis
V Sundaresan, I C Forgacs, D G Wight, et al.
Cell Death & Disease
|
January 26, 2013
Sequential Cdk1 and Plk1 phosphorylation of protein tyrosine phosphatase 1B promotes mitotic cell death
D S O'Donovan, S MacFhearraigh, J Whitfield, et al.
The EMBO Journal
|
October 1, 1986
Restricted expression of EBV latent genes and T-lymphocyte-detected membrane antigen in Burkitt's lymphoma cells
D T Rowe, M Rowe, G I Evan, et al.
Experimental Nephrology
|
March 1, 1994
Transduction pathways for growth stimulatory and inhibitory actions of vasoactive agents
A C Newby, J W Assender, M A Evans, et al.
Page
of 11